Format
Sort by
Items per page

Send to

Choose Destination

Best matches for STEM CELL TRANSPLANTATION:

Stem Cell Therapies in Clinical Trials: Progress and Challenges. Trounson A et al. Cell Stem Cell. (2015)

Progress of Stem Cell Transplantation for Treating Myocardial Infarction. Chen Z et al. Curr Stem Cell Res Ther. (2017)

Allogeneic stem cell transplantation for nonmalignant diseases. Bacigalupo A et al. Curr Opin Hematol. (2016)

Search results

Items: 1 to 20 of 123150

1.

Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.

Jarvis KB, LeBlanc M, Tulstrup M, Nielsen RL, Albertsen BK, Gupta R, Huttunen P, Jónsson ÓG, Rank CU, Ranta S, Ruud E, Saks K, Trakymiene SS, Tuckuviene R, Schmiegelow K.

Thromb Res. 2019 Nov 7;184:92-98. doi: 10.1016/j.thromres.2019.11.002. [Epub ahead of print]

PMID:
31715544
2.

Follistatin and Soluble Endoglin Predict 1-year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant.

Newell LF, DeFor TE, Cutler C, Verneris MR, Blazar BR, Miller JS, Antin JH, Howard A, Wu J, MacMillan ML, Panoskaltsis-Mortari A, Weisdorf DJ, Holtan SG.

Biol Blood Marrow Transplant. 2019 Nov 9. pii: S1083-8791(19)30746-3. doi: 10.1016/j.bbmt.2019.11.006. [Epub ahead of print]

PMID:
31715306
3.

A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009 - 2015.

Valentine JC, Morrissey CO, Tacey MA, Liew D, Patil S, Ananda-Rajah M.

Mycoses. 2019 Nov 12. doi: 10.1111/myc.13033. [Epub ahead of print]

PMID:
31715052
4.

Large-scale Production of LGR5-positive Bipotential Human Liver Stem Cells.

Schneeberger K, Sánchez-Romero N, Ye S, van Steenbeek FG, Oosterhoff LA, Pla Palacin I, Chen C, van Wolferen ME, van Tienderen G, Lieshout R, Colemonts-Vroninks H, Schene I, Hoekstra R, Verstegen MMA, van der Laan LJW, Penning LC, Fuchs SA, Clevers H, De Kock J, Baptista PM, Spee B.

Hepatology. 2019 Nov 12. doi: 10.1002/hep.31037. [Epub ahead of print]

PMID:
31715015
5.

Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis.

Arruda LCM, Gaballa A, Uhlin M.

Blood Adv. 2019 Nov 12;3(21):3436-3448. doi: 10.1182/bloodadvances.2019000682.

PMID:
31714966
6.

Microbiota modification in hematology: still at the bench or ready for the bedside?

Severyn CJ, Brewster R, Andermann TM.

Blood Adv. 2019 Nov 12;3(21):3461-3472. doi: 10.1182/bloodadvances.2019000365.

PMID:
31714965
7.

Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia.

Huang QS, Wang JZ, Qin YZ, Zeng QZ, Jiang Q, Jiang H, Lu J, Liu HX, Liu Y, Wang JB, Su L, Zhang HY, Li ZL, Gao SJ, Huang B, Liu YY, Liu YR, Xu LP, Huang XJ, Zhang XH.

Blood Adv. 2019 Nov 12;3(21):3406-3418. doi: 10.1182/bloodadvances.2019000564.

PMID:
31714962
8.

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling.

Bader P, Salzmann-Manrique E, Balduzzi A, Dalle JH, Woolfrey AE, Bar M, Verneris MR, Borowitz MJ, Shah NN, Gossai N, Shaw PJ, Chen AR, Schultz KR, Kreyenberg H, Di Maio L, Cazzaniga G, Eckert C, van der Velden VHJ, Sutton R, Lankester A, Peters C, Klingebiel TE, Willasch AM, Grupp SA, Pulsipher MA.

Blood Adv. 2019 Nov 12;3(21):3393-3405. doi: 10.1182/bloodadvances.2019000449.

PMID:
31714961
9.

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Thol F, Platzbecker U.

Blood Adv. 2019 Nov 12;3(21):3449-3453. doi: 10.1182/bloodadvances.2018022434.

PMID:
31714960
10.

Deep learning predicts function of live retinal pigment epithelium from quantitative microscopy.

Schaub NJ, Hotaling NA, Manescu P, Padi S, Wan Q, Sharma R, George A, Chalfoun J, Simon M, Ouladi M, Simon CG Jr, Bajcsy P, Bharti K.

J Clin Invest. 2019 Nov 12. pii: 131187. doi: 10.1172/JCI131187. [Epub ahead of print]

PMID:
31714897
11.

Human Autologous iPSC-Derived Dopaminergic Progenitors Restore Motor Function in Parkinson's Disease Models.

Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen B, Teicher M, Leblanc P, Carter B, Kordower JH, Bolshakov VY, Kong SW, Schweitzer JS, Kim KS.

J Clin Invest. 2019 Nov 12. pii: 130767. doi: 10.1172/JCI130767. [Epub ahead of print]

PMID:
31714896
12.

Salvage therapy for relapsed testicular cancer: a need for consensus.

Agrawal V, Adra N.

Future Oncol. 2019 Nov 12. doi: 10.2217/fon-2019-0531. [Epub ahead of print] No abstract available.

PMID:
31714157
13.

Characteristics of graft-versus-host disease occurring after alemtuzumab-containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and survival.

Finazzi MC, Boschini C, Craddock C, Rambaldi A, Ward J, Malladi RK.

Br J Haematol. 2019 Nov 12. doi: 10.1111/bjh.16200. [Epub ahead of print]

PMID:
31713861
14.

Prognostic significance of low pre-transplant skeletal muscle mass on survival outcomes in patients undergoing hematopoietic stem cell transplantation.

Sakatoku K, Ito A, Tajima K, Yamaguchi K, Kuno M, Aoki N, Tanaka T, Kurosawa S, Inamoto Y, Kim SW, Fukuda T.

Int J Hematol. 2019 Nov 12. doi: 10.1007/s12185-019-02773-0. [Epub ahead of print]

PMID:
31713713
15.

Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation Group.

Izumi K, Kanda J, Nishikori M, Arai Y, Ishikawa T, Yoshioka S, Ueda Y, Maeda T, Yonezawa A, Anzai N, Moriguchi T, Imada K, Akasaka T, Nohgawa M, Itoh M, Aiba A, Tsunemine H, Watanabe M, Kondo T, Takaori-Kondo A.

Ann Hematol. 2019 Nov 12. doi: 10.1007/s00277-019-03835-3. [Epub ahead of print]

PMID:
31713653
16.

Co-Transplantion of Wharton's jelly mesenchymal stem cell-derived osteoblasts with differentiated endothelial cells does not stimulate blood vessel and osteoid formation in nude mice models.

Naudot M, Barre A, Caula A, Sevestre H, Dakpé S, Mueller AA, Devauchelle B, Testelin S, Marolleau JP, Le Ricousse S.

J Tissue Eng Regen Med. 2019 Nov 11. doi: 10.1002/term.2989. [Epub ahead of print]

PMID:
31713308
17.

Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial.

Raoufinejad K, Shamshiri AR, Pezeshki S, Chahardouli B, Hadjibabaie M, Jahangard-Rafsanjani Z, Gholami K, Rajabi M, Vaezi M.

Daru. 2019 Nov 11. doi: 10.1007/s40199-019-00306-y. [Epub ahead of print]

PMID:
31713184
18.

Novel DDX41 variants in Thai patients with myeloid neoplasms.

Polprasert C, Takeda J, Niparuck P, Rattanathammethee T, Pirunsarn A, Suksusut A, Kobbuaklee S, Wudhikarn K, Lawasut P, Kongkiatkamon S, Chuncharunee S, Songserm K, Phowthongkum P, Bunworasate U, Nannya Y, Yoshida K, Makishima H, Ogawa S, Rojnuckarin P.

Int J Hematol. 2019 Nov 11. doi: 10.1007/s12185-019-02770-3. [Epub ahead of print]

PMID:
31713024
19.

Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantation.

Hamada R, Kondo T, Murao M, Miyasaka J, Yoshida M, Nankaku M, Kanda J, Takaori-Kondo A, Ikeguchi R, Matsuda S.

Support Care Cancer. 2019 Nov 12. doi: 10.1007/s00520-019-05124-1. [Epub ahead of print]

PMID:
31712955
20.

Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans.

Nakasone H, Kikuchi M, Kawamura K, Akahoshi Y, Sato M, Kawamura S, Yoshino N, Takeshita J, Yoshimura K, Misaki Y, Gomyo A, Tanihara A, Kusuda M, Tamaki M, Kimura SI, Kako S, Kanda Y.

Sci Rep. 2019 Nov 11;9(1):16499. doi: 10.1038/s41598-019-53020-9.

PMID:
31712609

Supplemental Content

Loading ...
Support Center